Retatrutide 30mg

Description

Retatrutide 30mg | Triple Receptor Agonist Peptide | GLP-1 · GIP · Glucagon

Retatrutide (LY3437943) is a synthetic acylated peptide and investigational triple receptor agonist with documented binding activity at three distinct G-protein coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). As the first publicly characterized triple incretin receptor agonist peptide to enter advanced clinical investigation, Retatrutide represents a significant development in the pharmacology of multi-receptor incretin system research and has rapidly become one of the most closely followed compounds in the metabolic peptide research landscape.

Structurally, Retatrutide is a fatty acid-acylated peptide engineered for extended half-life via albumin binding, achieved through conjugation of a C18 fatty diacid moiety to a gamma-glutamic acid linker at the lysine residue. This acylation strategy, well-established in the GLP-1 analog peptide research field, confers the prolonged plasma residence time that has made Retatrutide a particularly relevant tool compound for researchers studying sustained incretin receptor engagement, multi-receptor pharmacodynamic modeling, and structure-activity relationships within the glucagon peptide superfamily.

The compound’s simultaneous agonism at GLP-1R, GIPR, and GCGR positions it as a uniquely valuable research tool for investigators studying the interplay between these three receptor systems within the broader incretin axis, energy homeostasis signaling networks, and pancreatic beta cell biology in controlled in vitro and in vivo laboratory settings. Its advanced clinical research profile and extensive published pharmacological characterization make it one of the most data-rich investigational peptides currently available for academic and preclinical research applications.

Santa Cruz Peptides’ Retatrutide 30mg is supplied as a lyophilized powder under inert atmosphere in a larger-format vial specifically configured for extended research protocols, high-throughput laboratory applications, and multi-experiment study designs requiring greater compound availability. Each batch is independently verified for sequence integrity, acylation confirmation, purity, and molecular weight via HPLC and mass spectrometry. A full certificate of analysis is included with every batch.

Intended strictly for research purposes. Not for human or veterinary use. Not for consumption. For laboratory and investigative use only.

Specifications